Choroid and Retina: A potential guide for glycemic controlof diabetes mellitus without diabetic retinopathy

Aim: A considerable amount of evidence is pointing out the possible contribution of neurodegeneration in the etiopathogenesis of diabetic retinopathy (DR). Materials and Methods: The evaluation and correlation of the neurodegenerative findings in the inner retinal layers with the choroid of patients with type 2 diabetes mellitus (DM) without DR via optic coherence tomography (OCT) are aimed in this study. Results: Neuronal and axonal loss seems to occur early in DM before the ophthalmoscopic vascular changes. Conclusion: Strict glycemic control, in addition to neuroprotective measures in this pre-retinopathy phase may offer a promising treatment choice by decelerating the progression to overt retinopathy.

PDF

___

1. Yau JW, Rogers SL, Kawasaki R, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
2. Barber AJ, Lieth E, Khin SA, et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-91.
3. Barber AJ. A new view of diabetic retinopathy: A neurodegenerative disease of the eye. Prog. Neuropsychopharmacol Biol Psychiatry 2003;27:283- 90.
4. Han Y, Adams AJ, Bearse MA, Jr, et al. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 2004;122:1809-15.
5. Balta O, Sungur G, Yakin M, et al. Pattern visual evoked potential changes in diabetic patients without retinopathy. J Ophthalmol 2017;2017:8597629.
6. Drasdo N, Chiti Z, Owens DR, et al. Effect of darkness on inner retinal hypoxia in diabetes. Lancet 2002;359:2251-3.
7. Sokol S, Moskowitz A, Skarf B, et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985;103:51-4.
8. Roy MS, Gunkel RD, Podgor MJ. Color Vision Defects in Early Diabetic Retinopathy. Arch Ophthalmol. 1986;104:225-8.
9. Barber AJ, Baccouche B. Neurodegeneration in diabetic retinopathy: Potential for novel therapies. Vision Res 2017;139:82-92.
10. Massin P, Vicaut E, Haouchine B, et al. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119:1135-42.
11. van Dijk HW, Verbraak FD, Kok PH, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci 2012;53:2715-9.
12. van Dijk HW, Verbraak FD, Kok PHB, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010;513660-5.
13. Pierro L, Iuliano L, Cicinelli MV, et al. Retinal neurovascular changes appear earlier in type 2 diabetic patients. Eur J Ophthalmol 2017;27:346-51.
14. Ferreira JT, Vicente A, Proença R, et al. Choroidal thickness in diabetic patients without diabetic retinopathy. Retina 2018;38:795-804.
15. Kadlubowska J, Malaguarnera L, Waz P, et al. Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr Neuropharmacol 2016;14:831-9.
16. Chhablani J, Sharma A, Goud A, et al. Neurodegeneration in type 2 diabetes: evidence from spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2015;56:6333-8.
17. Ferreira JT, Proença R, Alves M, et al. Retina and Choroid of Diabetic Patients Without Observed Retinal Vascular Changes: A Longitudinal Study, Am J Ophthalmol 2017;176:15-25
18. Shawky SS, Elagouz MH, Ismail AM, et al. Macular thickness in healthy controls and diabetics without diabetic macular edema. Egyptian Retina J 2018;5:1- 5.
19. Verma A, Raman R, Vaitheeswaran K, et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy? Ophthalmic Res 2012;47:202-7.
20. Bronson-Castain KW, Bearse MA Jr, Neuville J, et al. Adolescents with type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina 2009;29:618-26.
21. Van Dijk HW, Verbraak FD, Stehouwer M et al. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res 2011:51:224-8.
22. Gundogan FC, Akay F, Uzun S, et al. Early neurodegeneration of the inner retinal layers in type 1 diabetes mellitus. Ophthalmologica 2016;235:125– 32.
23. Sohn EH, van Dijk HW, Jiao C, et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci USA 2016;113:2655-64.
24. Demirkaya N, van Dijk HW, van Schuppen SM, et al. Effect of age on individual retinal layer thickness in normal eyes as measured with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:4934-40.
25. Hegazy AI, Zedan RH, Macky TA, et al. Retinal ganglion cell complex changes using spectral domain optical coherence tomography in diabetic patients without retinopathy. Int J Ophthalmol 2017;10:42733.
26. Pincelli Netto M, Castro Lima V, Pacheco MA, et al. Macular Inner Retinal Layer Thinning in Diabetic Patients without Retinopathy Measured by Spectral Domain Optical Coherence Tomography. Med Hypothesis Discov Innov Ophthalmol 2018;7:133-9.
27. Vujosevic S Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. J Diabetes Res 2013;2013:905058.
28. Choi JA, Kim HW, Kwon JW, et al. Early inner retinal thinning and cardiovascular autonomic dysfunction in type 2 diabetes. PLoS One 2017;12:e0174377.
29. Fryczkowski AW, Sato SE, Hodes BL. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol 1988;20:299- 305.
30. Fryczkowski AW, Hodes BL, Walker J. Diabetic choroidal and iris vasculature scanning electron microscopy findings. Int Ophthalmol 1989;13:269–79.
31. Nagaoka T , Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 2004;88:1060-3.
32. Esmaeelpour M, Považay B, Hermann B, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1,060 nm optical coherence tomography. Invest Ophthalmol Vis Sci 2011;52:5311-6.
33. Xu J, Xu L, Du KF, et al. Subfoveal choroidal thickness in diabetes and diabetic retinopathy. Ophthalmology 2013;120:2023-8.
34. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53:6017- 24
35. Vujosevic S, Martini F, Cavarzeran F, et al. Macular and peripapillary choroidal thickness in diabetic patients. Retina 2012;32:1781-90.
36. Endo H, Kase S, Ito Y, et al. Relationship between choroidal structure and duration of diabetes. Graefes Arch Clin Exp Ophthalmol 2019;257:1133-40.
37. Farias LB, Lavinsky D, Benfica CZ, et al. Changes in choroidal thickness and volume are related to urinary albumin excretion in type 2 diabetic patients without retinopathy. Clin Ophthalmol 2018;12:1405-11.
38. Melancia D, Vicente A, Cunha JP, et al. Diabetic choroidopathy: A review of the current literature. Graefes Arch Clin Exp Ophthalmol 2016;254:1453-61.
39. Campos A, Campos EJ, Martins J, et al. Viewing the choroid: Where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema. Acta Ophthalmol 2017;95:446-59.
40. Cao D, Yang D, Huang Z et al. Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy. Acta Diabetol 2018;55:469-77.